MEDIO Stock Overview
Develops, produces, services, leases, and distributes medical devices for cardiac and vascular surgery in the United States, Europe, Asia, and internationally.
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 2/6 |
Past Performance | 3/6 |
Financial Health | 6/6 |
Dividends | 5/6 |
Medistim ASA Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | NOK 176.00 |
52 Week High | NOK 181.50 |
52 Week Low | NOK 175.00 |
Beta | 0.94 |
11 Month Change | n/a |
3 Month Change | n/a |
1 Year Change | n/a |
33 Year Change | n/a |
5 Year Change | n/a |
Change since IPO | 0.57% |
Recent News & Updates
No updates
Recent updates
No updates
Shareholder Returns
MEDIO | SE Medical Equipment | SE Market | |
---|---|---|---|
7D | -0.8% | 1.1% | 1.9% |
1Y | n/a | 20.7% | 24.3% |
Return vs Industry: Insufficient data to determine how MEDIO performed against the Swedish Medical Equipment industry.
Return vs Market: Insufficient data to determine how MEDIO performed against the Swedish Market.
Price Volatility
MEDIO volatility | |
---|---|
MEDIO Average Weekly Movement | n/a |
Medical Equipment Industry Average Movement | 7.6% |
Market Average Movement | 5.6% |
10% most volatile stocks in SE Market | 11.8% |
10% least volatile stocks in SE Market | 3.2% |
Stable Share Price: MEDIO has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine MEDIO's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1984 | 151 | Kari Krogstad | www.medistim.com |
Medistim ASA develops, produces, services, leases, and distributes medical devices for cardiac and vascular surgery in the United States, Europe, Asia, and internationally. The company offers MiraQ Cardiac, a system that combines ultrasound imaging and transit time flow measurement (TTFM) in a single system for cardiac surgery; MiraQ Vascular, a system that combines ultrasound imaging and TTFM in a single system for vascular surgery; MiraQ Ultimate that combines TTFM and ultrasound imaging in a single system for cardiac, vascular, and transplant surgery; and imaging probes for intraoperative use. It also provides QuickFit TTFM probes, which is designed to hold the vessel and ensure precise measurements on various types of vessel grafts; Vascular TTFM probes for locking slide mechanism designed to secure the vessel while minimizing the manipulation of fragile or calcified vessels; and Doppler probes that are used to search for intramural coronary arteries or to locate the position and quantify the degree of a stenosis.
Medistim ASA Fundamentals Summary
MEDIO fundamental statistics | |
---|---|
Market cap | NOK 3.24b |
Earnings (TTM) | NOK 104.34m |
Revenue (TTM) | NOK 533.17m |
31.1x
P/E Ratio6.1x
P/S RatioIs MEDIO overvalued?
See Fair Value and valuation analysisEarnings & Revenue
MEDIO income statement (TTM) | |
---|---|
Revenue | NOK 533.17m |
Cost of Revenue | NOK 110.42m |
Gross Profit | NOK 422.75m |
Other Expenses | NOK 318.41m |
Earnings | NOK 104.34m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
Oct 24, 2024
Earnings per share (EPS) | 5.70 |
Gross Margin | 79.29% |
Net Profit Margin | 19.57% |
Debt/Equity Ratio | 0% |
How did MEDIO perform over the long term?
See historical performance and comparison